Dr. Ahmed Obeidat, MD, PhD, discusses challenges with conventional MRI in monitoring multiple sclerosis (MS). He advocates for advanced techniques like volume metrics and fluid biomarkers, emphasizing their potential to enhance patient understanding and assess disease control in a comprehensive manner.
Source NeuroScienceNews
